<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35216298</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2184</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23042184</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progressive degeneration of upper and lower motor neurons that causes paralysis and muscle atrophy. The pathogenesis of the disease is still not elucidated. Receptor for Advanced Glycation End Product (RAGE) is a major component of the innate immune system and has implications in ALS pathogenesis. Multiple studies suggest the role of RAGE and its ligands in ALS. RAGE and its ligands are overexpressed in human and murine ALS motor neurons, astrocytes, and microglia. Here, we demonstrated the expression of RAGE and its ligands during the progression of the disease in the transgenic SOD1 G93A mouse lumbar spinal cord. We observed the highest expression of HMGB1 and S100b proteins at ALS onset. Our results highlight the potential role of RAGE and its ligands in ALS pathogenesis and suggest that some of the RAGE ligands might be used as biomarkers in early ALS diagnosis and potentially be useful in targeted therapeutic interventions at the early stage of this devastating disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nowicka</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0468-4046</Identifier><AffiliationInfo><Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szyma&#x144;ska</LastName><ForeName>Kamila</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juranek</LastName><ForeName>Judyta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zglejc-Waszak</LastName><ForeName>Kamila</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6577-7545</Identifier><AffiliationInfo><Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korytko</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0137-7649</Identifier><AffiliationInfo><Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Za&#x142;&#x119;cki</LastName><ForeName>Micha&#x142;</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1626-218X</Identifier><AffiliationInfo><Affiliation>Department of Animal Anatomy, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chmielewska-Krzesi&#x144;ska</LastName><ForeName>Ma&#x142;gorzata</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1670-0234</Identifier><AffiliationInfo><Affiliation>Department of Pathophysiology, Forensic Veterinary Medicine and Administration, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#x105;sowicz</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, Forensic Veterinary Medicine and Administration, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojtkiewicz</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0856-3644</Identifier><AffiliationInfo><Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>61.610.001-300</GrantID><Agency>Statute Fund of the Medical 494 School, Collegium Medicum</Agency><Country/></Grant><Grant><GrantID>OPUS/2017/25/B/NZ4/00435</GrantID><Agency>National Science Center</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000593873">Ager protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067759">Receptor for Advanced Glycation End Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067759" MajorTopicYN="Y">Receptor for Advanced Glycation End Products</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">RAGE</Keyword><Keyword MajorTopicYN="N">SOD1 G93A</Keyword><Keyword MajorTopicYN="N">ligands</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">transgenic mice</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35216298</ArticleId><ArticleId IdType="pmc">PMC8880540</ArticleId><ArticleId IdType="doi">10.3390/ijms23042184</ArticleId><ArticleId IdType="pii">ijms23042184</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., Van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowicka N., Juranek J., Juranek J.K., Wojtkiewicz J. Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2019;20:2616. doi: 10.3390/ijms20112616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112616</ArticleId><ArticleId IdType="pmc">PMC6600314</ArticleId><ArticleId IdType="pubmed">31141951</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031&#x2013;2041. doi: 10.1016/S0140-6736(07)60944-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60944-1</ArticleId><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700.</Citation><ArticleIdList><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis A.A., Leyns C.E.G., Holtzman D.M. Intercellular Spread of Protein Aggregates in Neurodegenerative Disease. Annu. Rev. Cell Dev. Biol. 2018;34:545&#x2013;568. doi: 10.1146/annurev-cellbio-100617-062636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100617-062636</ArticleId><ArticleId IdType="pmc">PMC6350082</ArticleId><ArticleId IdType="pubmed">30044648</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Cozzolino M., Carri M.T. Old versus New Mechanisms in the Pathogenesis of ALS. Brain Pathol. 2016;26:276&#x2013;286. doi: 10.1111/bpa.12355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12355</ArticleId><ArticleId IdType="pmc">PMC8029354</ArticleId><ArticleId IdType="pubmed">26779612</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E., Haass C., Dormann D. Stress granules in neurodegeneration&#x2014;Lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. FEBS J. 2013;280:4348&#x2013;4370.</Citation><ArticleIdList><ArticleId IdType="pubmed">23587065</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z., Liu N., Wang C., Qin B., Zhou Y., Xiao M., Zhao B. Role of RAGE in Alzheimer&#x2019;s Disease. Cell Mol. Neurobiol. 2016;36:483&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pubmed">26175217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C.G., Lee H., Lee S.B. Mechanisms of protein toxicity in neurodegenerative diseases. Cell Mol. Life Sci. 2018;75:3159&#x2013;3180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063327</ArticleId><ArticleId IdType="pubmed">29947927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguly G., Chakrabarti S., Chatterjee U., Saso L. Proteinopathy, oxidative stress and mitochondrial dysfunction: Cross talk in Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease. Drug Des. Devel. Ther. 2017;11:797&#x2013;810. doi: 10.2147/DDDT.S130514.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S130514</ArticleId><ArticleId IdType="pmc">PMC5358994</ArticleId><ArticleId IdType="pubmed">28352155</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992;267:14998&#x2013;15004. doi: 10.1016/S0021-9258(18)42138-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)42138-2</ArticleId><ArticleId IdType="pubmed">1378843</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt A.M., Mora R., Cao R., Yan S.D., Brett J., Ramakrishnan R., Tsang T.C., Simionescu M., Stern D. The endothelial cell binding site for advanced glycation end products consists of a complex: An integral membrane protein and a lactoferrin-like polypeptide. J. Biol. Chem. 1994;269:9882&#x2013;9888. doi: 10.1016/S0021-9258(17)36965-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)36965-X</ArticleId><ArticleId IdType="pubmed">8144581</ArticleId></ArticleIdList></Reference><Reference><Citation>Derk J., MacLean M., Juranek J., Schmidt A.M. The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration. J. Alzheimers Dis. Park. 2018;8:421. doi: 10.4172/2161-0460.1000421.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2161-0460.1000421</ArticleId><ArticleId IdType="pmc">PMC6293973</ArticleId><ArticleId IdType="pubmed">30560011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy R., Yan S.F., Schmidt A.M. Advanced glycation endproducts: From precursors to RAGE: Round and round we go. Amino Acids. 2012;42:1151&#x2013;1161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3062728</ArticleId><ArticleId IdType="pubmed">20957395</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbani N., Thornalley P.J. Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease. Biochem. Biophys Res. Commun. 2015;458:221&#x2013;226. doi: 10.1016/j.bbrc.2015.01.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.01.140</ArticleId><ArticleId IdType="pubmed">25666945</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorci G., Riuzzi F., Giambanco I., Donato R. RAGE in tissue homeostasis, repair and regeneration. Biochim. Biophys Acta. 2013;1833:101&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">23103427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.J., Vargas M.R., Harlan B.A., Killoy K.M., Ball L.E., Comte-Walters S., Gooz M., Yamamoto Y., Beckman J.S., Barbeito L., et al. Nitration and Glycation Turn Mature NGF into a Toxic Factor for Motor Neurons: A Role for p75(NTR) and RAGE Signaling in ALS. Antioxid Redox Signal. 2018;28:1587&#x2013;1602. doi: 10.1089/ars.2016.6966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2016.6966</ArticleId><ArticleId IdType="pmc">PMC5962334</ArticleId><ArticleId IdType="pubmed">28537420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray R., Juranek J.K., Rai V. RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis. Neurosci. Biobehav. Rev. 2016;62:48&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">26724598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu D., Zhu Z., Zhou A., Yun C.-H., Lee K.-E., Toms A.V., Li Y., Dunn G.P., Chan E., Thai T., et al. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 2013;3:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863638</ArticleId><ArticleId IdType="pubmed">23453972</ArticleId></ArticleIdList></Reference><Reference><Citation>Paudel Y.N., Shaikh M.F., Chakraborti A., Kumari Y., Aledo-Serrano A., Aleksovska K., Alvim M.K.M., Othman I. HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction. Front. Neurosci. 2018;12:628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142787</ArticleId><ArticleId IdType="pubmed">30271319</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Antoine D.J., Andersson U., Tracey K.J. The many faces of HMGB1: Molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J. Leukoc. Biol. 2013;93:865&#x2013;873. doi: 10.1189/jlb.1212662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1212662</ArticleId><ArticleId IdType="pmc">PMC4051189</ArticleId><ArticleId IdType="pubmed">23446148</ArticleId></ArticleIdList></Reference><Reference><Citation>Michetti F., Corvino V., Geloso M.C., Lattanzi W., Bernardini C., Serpero L., Gazzolo D. The S100B protein in biological fluids: More than a lifelong biomarker of brain distress. J. Neurochem. 2012;120:644&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">22145907</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano A., Donno C., Giannetti S., Peri&#x107; M., Andjus P., D&#x2019;Ambrosi N., Michetti F. The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1(G93A) Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes. Mediators Inflamm. 2017;2017:1626204. doi: 10.1155/2017/1626204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/1626204</ArticleId><ArticleId IdType="pmc">PMC5496121</ArticleId><ArticleId IdType="pubmed">28713206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruminis-Kaszkiel E., Juranek J., Maksymowicz W., Wojtkiewicz J. CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS) Int. J. Mol. Sci. 2018;19:906. doi: 10.3390/ijms19030906.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030906</ArticleId><ArticleId IdType="pmc">PMC5877767</ArticleId><ArticleId IdType="pubmed">29562705</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruminis-Kaszkiel E., Wojtkiewicz J., Maksymowicz W. Glial-restricted precursors as potential candidates for ALS cell-replacement therapy. Acta Neurobiol. Exp. 2014;74:233&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">25231843</ArticleId></ArticleIdList></Reference><Reference><Citation>Czarzasta J., Habich A., Siwek T., Czaplinski A., Maksymowicz W., Wojtkiewicz J. Stem cells for ALS: An overview of possible therapeutic approaches. Int. J. Dev. Neurosci. 2017;57:46&#x2013;55. doi: 10.1016/j.ijdevneu.2017.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdevneu.2017.01.003</ArticleId><ArticleId IdType="pubmed">28088365</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domenico F., Tramutola A., Butterfield D.A. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders. Free Radic. Biol. Med. 2017;111:253&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">27789292</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domenico F., Pupo G., Tramutola A., Giorgi A., Schinin&#xe0; M.E., Coccia R., Head E., Butterfield D.A., Perluigi M. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: Clues for understanding the development of Alzheimer disease. Free Radic. Biol. Med. 2014;71:270&#x2013;280. doi: 10.1016/j.freeradbiomed.2014.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.03.027</ArticleId><ArticleId IdType="pmc">PMC4686229</ArticleId><ArticleId IdType="pubmed">24675226</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon H.F., Hensley K., Thongboonkerd V., Merchant M.L., Lynn B.C., Pierce W.M., Klein J.B., Calabrese V., Butterfield D.A. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005;39:453&#x2013;462. doi: 10.1016/j.freeradbiomed.2005.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.03.030</ArticleId><ArticleId IdType="pubmed">16043017</ArticleId></ArticleIdList></Reference><Reference><Citation>Juranek J.K., Daffu G.K., Geddis M.S., Li H., Rosario R., Kaplan B.J., Kelly L., Schmidt A.M. Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice. Front. Cell Neurosci. 2016;10:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860390</ArticleId><ArticleId IdType="pubmed">27242430</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz M., Rodriguez H., Lopes C., Zuberi K., Montojo J., Bader G.D., Morris Q. GeneMANIA update 2018. Nucleic Acids Res. 2018;46:W60&#x2013;W64. doi: 10.1093/nar/gky311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky311</ArticleId><ArticleId IdType="pmc">PMC6030815</ArticleId><ArticleId IdType="pubmed">29912392</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.D., Liu N., Levin S.C., Ottosson L., Andersson U., Harris H.E., Woodruff T.M. Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J. Neuroinflamm. 2019;16:45. doi: 10.1186/s12974-019-1435-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1435-2</ArticleId><ArticleId IdType="pmc">PMC6380064</ArticleId><ArticleId IdType="pubmed">30782181</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckinghaus A., Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect Biol. 2009;1:a000034. doi: 10.1101/cshperspect.a000034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000034</ArticleId><ArticleId IdType="pmc">PMC2773619</ArticleId><ArticleId IdType="pubmed">20066092</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.J., Bickel P.J., Biggin M.D. System wide analyses have underestimated protein abundances and the importance of transcription in mammals. PeerJ. 2014;2:e270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3940484</ArticleId><ArticleId IdType="pubmed">24688849</ArticleId></ArticleIdList></Reference><Reference><Citation>Liscic R.M., Alberici A., Cairns N.J., Romano M., Buratti E. From basic research to the clinic: Innovative therapies for ALS and FTD in the pipeline. Mol. Neurodegener. 2020;15:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268618</ArticleId><ArticleId IdType="pubmed">32487123</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinle J.J. Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy. Cell Signal. 2020;73:109687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387203</ArticleId><ArticleId IdType="pubmed">32497617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.Y., Lee J.D., Phipps S., Noakes P.G., Woodruff T.M. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. J. Neuroinflamm. 2015;12:90. doi: 10.1186/s12974-015-0310-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0310-z</ArticleId><ArticleId IdType="pmc">PMC4431460</ArticleId><ArticleId IdType="pubmed">25962427</ArticleId></ArticleIdList></Reference><Reference><Citation>Casula M., Iyer A., Spliet W., Anink J., Steentjes K., Sta M., Troost D., Aronica E. Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue. Neuroscience. 2011;179:233&#x2013;243. doi: 10.1016/j.neuroscience.2011.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.02.001</ArticleId><ArticleId IdType="pubmed">21303685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 2010;28:367&#x2013;388. doi: 10.1146/annurev.immunol.021908.132603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132603</ArticleId><ArticleId IdType="pubmed">20192808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hyeon S.J., Im H., Ryu H., Kim Y., Ryu H. Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS. Exp. Neurobiol. 2016;25:233&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5081469</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu M.X., Requena J.R., Jenkins A.J., Lyons T.J., Baynes J.W., Thorpe S.R. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 1996;271:9982&#x2013;9986. doi: 10.1074/jbc.271.17.9982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.17.9982</ArticleId><ArticleId IdType="pubmed">8626637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi S., Shinpo K., Ogata A., Tsuji S., Takeuchi M., Makita Z., Tashiro K. Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2002;3:63&#x2013;68. doi: 10.1080/146608202760196020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608202760196020</ArticleId><ArticleId IdType="pubmed">12215227</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro J.P., Jung T., Grune T., Siems W. 4-Hydroxynonenal (HNE) modified proteins in metabolic diseases. Free Radic. Biol. Med. 2017;111:309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">27815191</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldogazieva N.T., Mokhosoev I.M., Mel&#x2019;nikova T.I., Porozov Y.B., Terentiev A.A. Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases. Oxid. Med. Cell Longev. 2019;2019:3085756. doi: 10.1155/2019/3085756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/3085756</ArticleId><ArticleId IdType="pmc">PMC6710759</ArticleId><ArticleId IdType="pubmed">31485289</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Wong M. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: A new target of disease mechanisms. Neurotherapeutics. 2013;10:722&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805862</ArticleId><ArticleId IdType="pubmed">23900692</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabais M.F., The Australian Imaging Biomarkers and Lifestyle study. Laws S.M., Lin T., Vallerga C.L., Armstrong N.J., Blair I.P., Kwok J.B., Mather K.A., Mellick G.D., et al. Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. Genome Biol. 2021;22:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8004462</ArticleId><ArticleId IdType="pubmed">33771206</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>